ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,556Medicare Part D Prescriptions Filled, Including Refills

Rank: 485 out of 2888

$511K Total Retail Price of All Prescriptions

Rank: 821 out of 2888

399 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

26% of this provider’s 399 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 9,697 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LEVOTHYROXINE SODIUM 563 521 1 1
AMLODIPINE BESYLATE 487 470 2 5
HYDROCODONE-ACETAMINOPHEN 457 379 S3 3 4
SIMVASTATIN 344 328 4 2
FUROSEMIDE 325 310 5 6
LISINOPRIL-HYDROCHLOROTHIAZIDE 290 274 6 28
METFORMIN HCL 280 261 7 8
OMEPRAZOLE 277 230 8 7
POTASSIUM CHLORIDE 271 253 9 14
LISINOPRIL 246 228 10 3
METOPROLOL SUCCINATE 244 239 11 11
PRAVASTATIN SODIUM 224 196 12 12
LOSARTAN POTASSIUM 198 197 13 18
CLONIDINE HCL 196 186 14 39
DIOVAN 160 145 15 35
GABAPENTIN 156 146 16 13
TRAMADOL HCL 155 143 17 16
TAMSULOSIN HCL 154 149 18 29
METOPROLOL TARTRATE 147 132 19 10
ATORVASTATIN CALCIUM 136 130 20 9
ATENOLOL 134 111 21 25
ALLOPURINOL 132 125 22 37
CRESTOR 125 125 23 20
FINASTERIDE 119 117 24 102
AZITHROMYCIN 115 105 25 38
ZOLPIDEM TARTRATE 115 107 25 17
DIOVAN HCT 109 109 27 61
PREDNISONE 107 106 28 42
CIPROFLOXACIN HCL 100 92 29 47
CEFDINIR 99 90 30 194
DONEPEZIL HCL 98 98 31 26
CLOPIDOGREL 86 86 32 30
LOSARTAN-HYDROCHLOROTHIAZIDE 77 77 33 46
NEXIUM 76 72 34 19
LOVASTATIN 73 67 35 41
WARFARIN SODIUM 73 66 35 22
SERTRALINE HCL 71 63 37 27
GLIMEPIRIDE 69 65 38 36
LYRICA 69 44 38 69
ISOSORBIDE MONONITRATE ER 69 58 38 51
HYDROCHLOROTHIAZIDE 68 68 41 15
GLYBURIDE 66 55 R 42 58
PLAVIX 65 65 43 40
LEVEMIR FLEXPEN 61 59 44 156
DIGOXIN 60 60 45 55
PROAIR HFA 58 51 46 71
DILTIAZEM 24HR ER 58 55 46 264
CARVEDILOL 57 51 48 21
SYNTHROID 56 46 49 52
COMBIVENT 53 53 50 177
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 14, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.